Effects of Probiotics on Gut Microbiota in Patients with Inflammatory Bowel Disease: A Double-blind, Placebo-controlled Clinical Trial.
10.4166/kjg.2015.65.4.215
- Author:
Mahdi SHADNOUSH
1
;
Rahebeh Shaker HOSSEINI
;
Ahad KHALILNEZHAD
;
Lida NAVAI
;
Hossein GOUDARZI
;
Maryam VAEZJALALI
Author Information
1. National Nutrition and Food Technology Research Institute, Faculty of Nutrition Sciences and Food Technology, Tehran, Iran. mshadnoush@gmail.com
- Publication Type:Clinical Trial ; Original Article
- Keywords:
Inflammatory bowel diseases;
Microbiota;
Probiotics
- MeSH:
Adult;
Bacteroides/genetics;
Bifidobacterium/genetics;
DNA, Bacterial/analysis;
Double-Blind Method;
Feces/microbiology;
Female;
Gastrointestinal Microbiome;
Humans;
Inflammatory Bowel Diseases/*drug therapy;
Intestines/microbiology;
Lactobacillus/genetics;
Male;
Middle Aged;
Placebo Effect;
Probiotics/*therapeutic use;
Real-Time Polymerase Chain Reaction
- From:The Korean Journal of Gastroenterology
2015;65(4):215-221
- CountryRepublic of Korea
- Language:English
-
Abstract:
BACKGROUND/AIMS: Several clinical trials have revealed various advantages for probiotics in inflammatory bowel disease (IBD). The aim of this study was to further investigate the effects of probiotic yogurt consumption on gut microbiota in patients with this disease. METHODS: A total of 305 participants were divided into three groups; group A (IBD patients receiving probiotic yogurt; n=105), group B (IBD patients receiving placebo; n=105), and control group (healthy individuals receiving probiotic yogurt; n=95). Stool samples were collected both before and after 8 weeks of intervention; and population of Lactobacillus, Bifidobacterium and Bacteroides in the stool specimens was measured by Taqman real-time PCR method. ': By the end of the intervention, no significant variations in the mean weight and body mass index were observed between three groups (p>0.05). However, the mean numbers of Lactobacillus, Bifidobacterium, and Bacteroides in group A were significantly increased compared to group B (p<0.001, p<0.001, and p<0.01, respectively). There were also significant differences in the mean numbers of either of three bacteria between group A and the healthy control group; however, these differences between two groups were observed both at baseline and the end of the intervention. CONCLUSIONS: Consumption of probiotic yogurt by patients with IBD may help to improve intestinal function by increasing the number of probiotic bacteria in the intestine and colon. However, many more studies are required in order to prove the concept.
